Zikria Saleem, Mobasher Ahmad, Furqan Khurshid Hashmi, Hamid Saeed, Muhammad Tahir Aziz
Doxorubicin and Cyclophosphamide (AC protocol) combination is usually considered as a first line therapy in newly diagnosed breast cancer patients
Doxorubicin-Cyclophosphamide
primary breast cancer
hepatic proteins
blood urea nitrogen (BUN).